Geode Capital Management LLC raised its position in Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 31.4% during the fourth quarter, according to its most recent filing with the SEC.

Lucid Diagnostics ( ($LUCD) ) has provided an update. On April 11, 2025, Lucid Diagnostics Inc. announced the closing of its public offering of ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...

Commonwealth Equity Services LLC lessened its holdings in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 3.6% in the 4th quarter, according to its most recent filing with the SEC.

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

Canaccord Genuity LLC acted as the sole bookrunner of the offering ... For more information about Lucid, please visit www.luciddx.com and for more information about its parent company PAVmed ...

Lucid Group Inc. has won a bankruptcy auction ... and convertible notes tied to Wabash Valley Resources Holdings LLC during the April 10 bankruptcy auction. Midwest Infrastructure Partners ...

Lucid Diagnostics Inc., markets the first and only commercial ... subject to customary closing conditions. Canaccord Genuity LLC is acting as the sole bookrunner of the offering and Maxim Group LLC is ...

Detailed price information for Mural Oncology Plc (MURA-Q) from The Globe and Mail including charting and trades.